共 13 条
[1]
Efficacy and safety of aripiprazole and haloperidol vs placebo in patients with schizophrenia and schizoaffective disorder. Kane JM,Carson WH,Saha AR,et al. Journal of Clinical Psychiatry . 2002
[2]
Aripirazole, a novel antipsychotic, is a high affinity partial agonist at human dopamine D2 receptors. Burns KD,Molski TF,Xu C,et al. Journal of Pharmacology and Experimental Therapeutics . 2002
[3]
Aripirazole in the treatment of schizophrenia: safety and tolerability in shortterm placebo- controlled trials. Marder SR,McQuade RD,Stock E,et al. Schizophrenia Research . 2003
[4]
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia or schizoaffective disorder. Potkin SG,Saha AR,Kujawa MJ,et al. Archives of General Psychiatry . 2003
[5]
The antipsychotic aripirazole is a potent, partial agonist at the human 5-HT1A receptor. Jordan S,Koprivica V,Chen R,et al. European Journal of Pharmacology . 2002
[6]
Aripirazole for long-term maintenance treatment of schizophrenia ( abstract). Kujawa M,Saha AR,Ingenito GG,et al. International Journal of Neuropsychiatry . 2002
[7]
Aripirazole: in acute mania associated with bipolar I disorder,adis drug profile. Katherine A,Lyseng-Williamson,Caroline M,et al. CNS Drugs . 2004
[8]
Aripiprazole versus haloperidol for maintained treatment effect in acute mania. Bourin M,Auby P,Swanink R,et al. In: New Research Abstracts of the 156 th Annual Meeting of the American Psychiatric Association; San Francisco, Calif. 2003 May 20, Abstract NR467 .
[9]
Meta-analysis of the efficacy of aripirazole in schizophrenia. Lieberman J,Carson WH,Saha AR,et al. Int J Neuropsychupharmacol . 2002
[10]
New developments in the pharmacotherapy of schizophrenia. Fleischhacker WW. Journal of Neural Transmission . 2003